Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sweden
Manufacturing
FDA stymies Camurus' drug over 3rd-party manufacturing issues
The FDA dealt Camurus a setback to its efforts to bring its treatment for the hormonal disorder acromegaly to market due to manufacturing issues.
Joseph Keenan
Oct 22, 2024 9:53am
AstraZeneca plans $135M expansion of Swedish manufacturing site
Aug 27, 2024 10:02am
Asahi Kasei moves to buy Calliditas for more than $1B
May 28, 2024 11:19am
AZ inks wind power deal with massive European energy company
Aug 9, 2023 1:22pm
Amarin makes strides in EU for fish-oil-derived heart drug
Mar 29, 2022 11:05am
Moderna plants 6 more pins on its commercial map
Feb 17, 2022 8:35am